US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Zyus Life Sciences Corporation (PK) (ZLSCF) 銘柄情報

Zyus Life Sciences Corporation (PK) (ZLSCF)

0.04

0.00

(0.00%)

終了 7月4日 5:00AM

Zyus Life Sciences Corporation (PK) (ZLSCF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.04

( - )

買値

0.0111

売値

0.258

出来高

-

0.00 日の範囲 0.00

0.000022 52 週間の範囲 0.58

時価総額

前日終値

0.04

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 8,930

発行済株式数

80,522,813

配当利回り

PER

-1.1

1 株当たり利益 (EPS)

-0.45

歳入

465k

純利益

-33.74M

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2... ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.zyus.com

本社

Saskatoon, Canada

設立

2026

Zyus Life Sciences Corporation (PK) is listed in the Healthcare sector of the その他OTC with ticker ZLSCF. The last closing price for Zyus Life Sciences (PK) was US$0.04. Over the last year, Zyus Life Sciences (PK) shares have traded in a share price range of US$ 0.000022 to US$ 0.58.

Zyus Life Sciences (PK) currently has 80,522,813 shares in issue. The market capitalisation of Zyus Life Sciences (PK) is US$3.22 million. Zyus Life Sciences (PK) has a price to earnings ratio (PE ratio) of -1.10.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0.04	0.04	0.04	13000	0.04	CS
12	-0.38	-90.4761904762	0.42	0.42	0.04	2104	0.11461827	CS
26	-0.51	-92.7272727273	0.55	0.57	0.04	4581	0.35029005	CS
52	-0.54	-93.1034482759	0.58	0.58	2.2E-5	3267	0.39888432	CS
156	-0.74	-94.8717948718	0.78	0.81	2.2E-5	3933	0.53043593	CS
260	-0.74	-94.8717948718	0.78	0.81	2.2E-5	3933	0.53043593	CS

ZLSCF - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences Corporation (PK) share price?

The current share price of Zyus Life Sciences Corporation (PK) is US$ 0.04

How many Zyus Life Sciences Corporation (PK) shares are in issue?

Zyus Life Sciences Corporation (PK) has 80,522,813 shares in issue

What is the market cap of Zyus Life Sciences Corporation (PK)?

The market capitalisation of Zyus Life Sciences Corporation (PK) is USD 3.22M

What is the 1 year trading range for Zyus Life Sciences Corporation (PK) share price?

Zyus Life Sciences Corporation (PK) has traded in the range of US$ 0.000022 to US$ 0.58 during the past year

What is the PE ratio of Zyus Life Sciences Corporation (PK)?

The price to earnings ratio of Zyus Life Sciences Corporation (PK) is -1.1

What is the cash to sales ratio of Zyus Life Sciences Corporation (PK)?

The cash to sales ratio of Zyus Life Sciences Corporation (PK) is 85.72

What is the registered address of Zyus Life Sciences Corporation (PK)?

The registered address for Zyus Life Sciences Corporation (PK) is Unit 204, Saskatoon, Saskatchewan, S7N 4L8

What is the Zyus Life Sciences Corporation (PK) website address?

The website address for Zyus Life Sciences Corporation (PK) is www.zyus.com

Which industry sector does Zyus Life Sciences Corporation (PK) operate in?

Zyus Life Sciences Corporation (PK) operates in the Pharmaceuticals sector

StonkMaster

StonkMaster 6分前

FDA approval just got derisked today.
They may be slow, but the data is the data.
Buying.

kenjiroo

kenjiroo 7分前

I agree … but we are halfway the FiFA gig ( after we kick the US out on monday ) remember .. Belgium -US !! @ ST3 … watch and learn how to do business !!! You faillied ! We aint … because .. we are belgians !! Google “Ambiorix” and you will understand !! We go way back !!

hedge_fun

hedge_fun 8分前

Who is the 3rd party that tested the…….

device?

Thx

Red Cloud

Red Cloud 8分前

WTF are you blithering about now...?

eliminate

eliminate 8分前

Happy 4th and thankyou everybody involved for cleaning

Up the Dishware in Iran I think one just needs to send the dishes through with another cycle of hot water

Optimus Research

Optimus Research 8分前

Doc has it right IMO. The way LP has stated what approval is and is not based on leaves a whole lot of wiggle room to read between the lines and get to Docs' conclusion. There will be riots in the streets once the general public learns about DCVax and the masses are denied treatment and forced into

Naught

Naught 10分前

Newflow

I think Gemini is contradicting herself on earlier distribution deployment dates. Very possibly sues to the way questions are worded to her. A s I recall the emphasis at one time was to distribute funds to holders prior to the expiration date. Now that seems to not be the cas

getmoreshares

getmoreshares 12分前

https://x.com/nettermike/status/2073067133878374851

Genz2

https://www.inc.com/jennifer-knowles/why-mackenzie-scott-chooses-silence-over-spotlight-in-her-billion-dollar-giving-strategy/91366706

Good article!!! It could give Elon some insights!!! Learn something new everyday Elon!!! The world could be kinder to you Elon if you were kinder t

getmoreshares

getmoreshares 12分前

https://x.com/nettermike/status/2073067133878374851

getmoreshares

getmoreshares 13分前

https://x.com/nettermike/status/2073067133878374851

getmoreshares

getmoreshares 13分前

https://x.com/nettermike/status/2073067133878374851

surfer44

surfer44 17分前

MID-SHIP Dry Bulk Freight Market Update - June 2026

https://youtu.be/BR2GoZoRjlU

TightCoil

TightCoil 18分前

FNMA/FMCC
Ask yourself, what will Fannie's PPS be in 2 weeks?
then Load Up Heavy - Strongest Buy - Load Now

hedge_fun

hedge_fun 19分前

Yesterday Kyle worded it differently and said Timmy’s…..

toy gave them a general area of where treasure was.

He also said they may need to rescan and recalibrate the device.

He also admitted they’ve missed every target.

But keep up the f

mikeo56

mikeo56 21分前

Sunnybank

Sunnybank 21分前

Just know he signed for 3 years and $47.4 million and Knicks sign Andre Drummond 1 year for $3.9 million. Cheaper, 1 inch shorter, better from free throw line. Step backward. Now rumoring LeBron to Knicks. Sheesh

PatB1

You're FOS! There is no way this is true! Where is the benefit if this is true!

WhenLambo

WhenLambo 22分前

It’s coming, FIFA put VuMe out there as a partnered media platform. These things don’t happen by accident or without thorough review ie contractual, licensing, data etc

Goats'nCrows

Goats'nCrows 22分前

The Man With the Golden Slides.
https://investorshub.advfn.com/uimage/uploads/2026/7/3/[zcicIMG_1331.jpeg

Truth_is_a_tool

Truth_is_a_tool 30分前

As I have repeatedly noted, the sericin coating around silk is not readily washable. That means you won’t see it in t-shirts, underwear, men’s pants, etc.

The sericin coating is removed during the de-gumming process so your point has no merit whatsoever. You do know there are regul

CA Market News

CA Market News 34分前

QcX Gold Announces Proposed Debt SettlementJuly 3, 2026 8:00 PM
NewsfileToronto, Ontario--(Newsfile Corp. - July 3, 2026) - QcX Gold Co

ATLnsider

ATLnsider 35分前

Doc, as you know, the MHRA will not make an initial DCVax-L approval decision based upon NWBio’s ability to meet full demand at initial approval.

The MHRA approval decision will be made based upon proven safety and efficacy, and the ability of NWBio / Advent to manufacture DCVax-L in

fuagf

Will never forget it.

trueblue

trueblue 41分前

There was pics of coins they buried inside boxes and the sea searcher pin pointed and showed them. I truly believe the technology they created works. Just a matter of time! Jmo

Zyus Life Sciences (PK)

Canadian Utilities (ID)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。